Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia > Understanding Chronic Lymphocytic Leukemia > Treatment Options for Chronic Lymphocytic Leukemia > Monoclonal Antibody Immunotherapy in Chronic Lymphocytic Leukemia

Previous Section

Next Section

Print Section

Email Section

Buy Guidebook

Treatment Options for Chronic Lymphocytic Leukemia

Monoclonal Antibody Immunotherapy in Chronic Lymphocytic Leukemia

Currently, there are several monoclonal antibodies in development for the treatment of CLL. Examples include:

Epratuzumab - a humanized monoclonal antibody targeting the CD22 antigen on B-cells
Apolizumab - a humanized monoclonal antibody directed against the 1D10 antigen on B-cells
Lumiliximab - an anti-CD23 monoclonal antibody

Next: Stem Cell Transplantation for Chronic Lymphocytic Leukemia

Visitor Feedback

"The Medifocus Guidebook is helping me to understand my condition much more in-depth than before. My doctor described the disease in medically technical terms only. I have used my Guidebook to access a variety of information sources and now have not only a better understanding of my ailment, but also several treatments have been revealed which I did not previously know about."

J.H., Nashville, Tennessee